CAH
Cardinal Health IncPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Year-to-date share repurchases | 750M | Q2 FY26 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CAH
this stock
Cardinal Health Inc
|
$52.93B | +12.5% | -1.9% | — | 3.0% |
|
MCK
Mckesson Corp
|
$95.75B | -2.0% | +3.1% | 20.8 | 3.4% |
|
COR
Cencora, Inc.
|
$57.70B | -10.3% | +9.3% | 22.7 | 2.8% |
|
HSIC
Henry Schein Inc
|
$9.93B | +15.0% | +5.9% | 26.3 | 6.3% |
|
EBOSY
EBOS Group Limited/ADR
|
$2.67B | -24.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CAH | -4.0% | +2.8% | +9.7% | -3.1% | +12.5% |
| SPY | +0.6% | +1.4% | +11.0% | +0.7% | +10.3% |
| vs SPY | -4.6% | +1.4% | -1.3% | -3.8% | +2.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.